(NASDAQ: SOPH) Sophia Genetics Sa's forecast annual revenue growth rate of 17.85% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 6.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Sophia Genetics Sa's revenue in 2026 is $90,972,000.On average, 7 Wall Street analysts forecast SOPH's revenue for 2026 to be $8,346,632,457, with the lowest SOPH revenue forecast at $7,991,578,716, and the highest SOPH revenue forecast at $8,625,792,925. On average, 7 Wall Street analysts forecast SOPH's revenue for 2027 to be $10,393,780,670, with the lowest SOPH revenue forecast at $9,569,747,622, and the highest SOPH revenue forecast at $11,523,613,924.
In 2028, SOPH is forecast to generate $12,817,054,571 in revenue, with the lowest revenue forecast at $11,584,431,332 and the highest revenue forecast at $15,333,696,042.